On Friday, the company announced it has acquired a U.S.-based peptide facility that will "further verticalize the company's long-term ability to deliver personalized medications." Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said
If you have any joint problems, heart conditions, or have been sedentary for several years, a brief check-in with your doctor before starting is wise
Quick shipping and great communication
Severe symptoms (chest pain, difficulty breathing, severe nausea) require emergency care
Experience the benefits of tirzepatide with the support and convenience only Klinic can provide